Analysis of FDA Data Reveals Further Evidence of Topamax Related Birth Defects according to Hissey K
Analysis of FDA Data Reveals Further Evidence of Topamax Related Birth Defects according to Hissey Kientz L.L.P. Over 37% of Topamax (http://www.hkllp.com/topamax/) related adverse event reports involving toddlers indicate serious birth defects which may be linked to use of the drug, according to data provided by the FDA’s Adverse Event Report database. In March 2011, the FDA warned that women who use Topamax during pregnancy are 21-times more likely to give birth to a child with oral cleft palate and cleft lip defects than non-users. Austin, TX (PRWEB) April 6, 2011 Over 37% of Topama
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 308
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4